Skip to content

Telerehabilitation Program and Detraining in Patients With Post-COVID-19 Sequelae

Effects of a Telerehabilitation Program and Detraining on Cardiorespiratory Fitness in Patients With Post-COVID-19 Sequelae

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05866224
Enrollment
130
Registered
2023-05-19
Start date
2021-01-01
Completion date
2023-05-01
Last updated
2023-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Brief summary

The primary objective of this study is to evaluate the effects of a 15-week home telerehabilitation program and a detraining period on cardiorespiratory fitness and muscular efficiency in patients with post-COVID-19 sequelae compared to a control group of COVID-19 patients. We hypothesize that cardiorespiratory fitness and muscular efficiency significantly improve in patients who carry out the home telerehabilitation program. However, the cardiorespiratory and muscular adaptations achieved and tolerance to exercise are lost over time as an effect of detraining.

Interventions

The supervised telerehabilitation program will be performed in the home of each patient and supervised by an experienced physiotherapist with more than 4 years of clinical experience in therapeutic exercise for chronic diseases.

Sponsors

Campus docent Sant Joan de Déu-Universitat de Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 18 years * molecular diagnosis (reverse transcription polymerase chain reaction \[RT-PCR\]) of infection by SARS-CoV-2 * post-COVID-19 symptomatology

Exclusion criteria

* severe neurological disease * active oncological disease * neuromuscular disease and/or orthopedic disorders impeding normal development of cardiopulmonary exercise test * the absence of signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory fitness: absolute oxygen uptake1 week per groupabsolute peak oxygen uptake in L/min
Cardiorespiratory fitness: relative oxygen uptake1 week per grouprelative peak oxygen uptake in L/min
Exercise capacity during cardiopulmonary exercise test1 week per groupExercise time in minutes and seconds
Mechanical efficiency1 week per groupDelta efficiency in percentage
Ventilatory efficiency1 week per groupVE/VCO2 slope
Power output during pedaling1 week per groupPower output in watts

Secondary

MeasureTime frameDescription
Respiratory exchange ratio1 week per groupRER
ventilatory equivalent for carbon dioxide1 week per groupVE/VCO2
ventilatory equivalent for oxygen1 week per groupVE/VO2
Minute ventilation1 week per groupVentilation in L/min
End-tidal partial pressure of oxygen1 week per groupPetO2 in mmHg
end-tidal partial pressure of carbon dioxide1 week per groupPetCO2 in mmHg
Weight of COVID-19 patients1 week per groupWeight in kg
Height of COVID-19 patients1 week per groupHeight in meters
Body mass index of COVID-19 patients1 week per groupBMI in kg/m2

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026